Clinicopathologic evaluation of CTNNB1 gene mutations in high-intermediate risk endometrial cancer

2021 ◽  
Vol 162 ◽  
pp. S114
Author(s):  
Jennifer Haag ◽  
Rebecca Wolsky ◽  
Marisa Moroney ◽  
Jamie Sheren ◽  
Jeanelle Sheeder ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Gene Mutations ◽  
Intermediate Risk ◽  
Ctnnb1 Gene

Abstract PO014: Clinicopathologic evaluation of CTNNB1 gene mutations in high-intermediate risk endometrial cancer

2021 ◽  
Author(s):  
Jennifer G. Haag ◽  
Rebecca J. Wolsky ◽  
Marisa R. Moroney ◽  
Jamie Sheren ◽  
Jeanelle Sheeder ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Gene Mutations ◽  
Intermediate Risk ◽  
Ctnnb1 Gene

Intravaginal brachytherapy alone for intermediate-risk endometrial cancer

2005 ◽  
Vol 62 (1) ◽  
pp. 111-117 ◽  
Author(s):  
Kaled M. Alektiar ◽  
Ennapadam Venkatraman ◽  
Dennis S. Chi ◽  
Richard R. Barakat
Keyword(s):  
Endometrial Cancer ◽  
Intermediate Risk

58: Use of Robotic Hysterectomy in Intermediate-Risk Endometrial Cancer

2021 ◽  
Vol 163 ◽  
pp. S27-S28
Author(s):  
Jiheon Song ◽  
Tien Le ◽  
Laura Hopkins ◽  
Michael Fung-Kee-Fung ◽  
Krystine Lupe ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Intermediate Risk ◽  
Robotic Hysterectomy

scholarly journals Cancer susceptibility gene mutations in type I and II endometrial cancer

2019 ◽  
Vol 152 (1) ◽  
pp. 20-25 ◽  
Author(s):  
Beverly Long ◽  
Jenna Lilyquist ◽  
Amy Weaver ◽  
Chunling Hu ◽  
Rohan Gnanaolivu ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Cancer Susceptibility ◽  
Susceptibility Gene ◽  
Gene Mutations ◽  
Type I ◽  
Cancer Susceptibility Gene

Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer

2007 ◽  
Vol 106 (2) ◽  
pp. 388-393 ◽  
Author(s):  
N. Calloway Rankins ◽  
A. Alvarez Secord ◽  
E. Jewell ◽  
L.J. Havrilesky ◽  
J.T. Soper ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Cost Effectiveness ◽  
Adjuvant Radiotherapy ◽  
Intermediate Risk
Sign in / Sign up

Export Citation Format

Share Document